AN1 0.00% 0.8¢ anagenics limited

Ann: Midkine Symposium Munich, page-14

  1. 551 Posts.
    lightbulb Created with Sketch. 173
    image.jpg
    With regards to this part of the announcement:

    Pfizer have a collaboration with the Velasco team (Crizotinib). I am sure that they are very well informed about Cellmid's own collaboration with Complutense/Velasco and will be watching closely the midkine antibody development. Might be interesting both as a standalone and combinational therapy.

    And it's good to see that the cannabinoid related studies continue, too.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
(20min delay)
Last
0.8¢
Change
0.000(0.00%)
Mkt cap ! $3.690M
Open High Low Value Volume
0.8¢ 0.8¢ 0.8¢ $336 42K

Buyers (Bids)

No. Vol. Price($)
3 1457234 0.8¢
 

Sellers (Offers)

Price($) Vol. No.
0.9¢ 340000 1
View Market Depth
Last trade - 14.19pm 12/07/2024 (20 minute delay) ?
AN1 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.